Sabra Healthcare REIT (NASDAQ:SBRA) Stock Rating Lowered by Wall Street Zen

Sabra Healthcare REIT (NASDAQ:SBRA) was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday.

A number of other equities research analysts have also weighed in on SBRA. UBS Group set a $19.00 price objective on shares of Sabra Healthcare REIT in a report on Thursday. Scotiabank dropped their target price on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating on the stock in a research note on Thursday. Cantor Fitzgerald raised their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Weiss Ratings downgraded shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research note on Thursday, June 4th. Finally, Truist Financial boosted their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a report on Friday, March 13th. Five research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Sabra Healthcare REIT presently has a consensus rating of “Hold” and a consensus target price of $21.80.

Sabra Healthcare REIT Stock Performance

SBRA stock opened at $18.12 on Friday. Sabra Healthcare REIT has a twelve month low of $17.17 and a twelve month high of $21.28. The firm has a market cap of $4.57 billion, a price-to-earnings ratio of 28.76, a PEG ratio of 1.35 and a beta of 0.64. The business’s fifty day simple moving average is $19.90 and its two-hundred day simple moving average is $19.65. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.16. The firm had revenue of $211.74 million during the quarter, compared to analyst estimates of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The business’s revenue was up 20.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Analysts predict that Sabra Healthcare REIT will post 1.5 earnings per share for the current year.

Hedge Funds Weigh In On Sabra Healthcare REIT

A number of hedge funds and other institutional investors have recently modified their holdings of SBRA. Rothschild Investment LLC increased its holdings in Sabra Healthcare REIT by 164.6% during the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 889 shares during the period. Smartleaf Asset Management LLC raised its stake in Sabra Healthcare REIT by 97.7% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 714 shares in the last quarter. Founders Capital Management purchased a new stake in Sabra Healthcare REIT during the third quarter worth $28,000. Strengthening Families & Communities LLC purchased a new stake in Sabra Healthcare REIT during the fourth quarter worth $29,000. Finally, Danske Bank A S bought a new stake in Sabra Healthcare REIT during the 3rd quarter valued at $30,000. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.